PharmAdapt: a randomized prospective study to evaluate the benefit of therapeutic monitoring of protease inhibitors: 12 week results (Q53949891)
scientific article
Language:
Current Data About PharmAdapt: a randomized prospective study to evaluate the benefit of therapeutic monitoring of protease inhibitors: 12 week results
(P31) (Q13442814)
(P248)
(P698) 12441803
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/12441803

(P304) 2311-2315
(P248)
(P698) 12441803
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/12441803

(P407) (Q1860)

(P433) 17
(P248)
(P698) 12441803
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/12441803

(P478) 16
(P248)
(P698) 12441803
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/12441803

(P577) Friday, November 1, 2002
(P248)
(P698) 12441803
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/12441803

(P1433) (Q4651863)
(P248)
(P698) 12441803
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/12441803

(P1476) "PharmAdapt: a randomized prospective study to evaluate the benefit of therapeutic monitoring of protease inhibitors: 12 week results" (language: en)
(P248)
(P698) 12441803
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/12441803

(P2093) Philippe Clevenbergh
(P1545) 1
(P248)
(P698) 12441803
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/12441803

Rodolphe Garraffo
(P1545) 2
(P248)
(P698) 12441803
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/12441803

Jacques Durant
(P1545) 3
(P248)
(P698) 12441803
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/12441803

Pierre Dellamonica
(P1545) 4
(P248)
(P698) 12441803
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/12441803

other details
description scientific article

External Links
(P356) 10.1097/00002030-200211220-00011
(P698) 12441803